Deliriant hallucinogens

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf Class of hallucinogens
gptkbp:compounds gptkb:Hyoscyamine
gptkb:Mandrake
gptkb:Datura
gptkb:Atropine
gptkb:Brugmansia
gptkb:Diphenhydramine
gptkb:Scopolamine
gptkb:Henbane
gptkbp:difference_from_dissociatives Produce realistic hallucinations and confusion rather than detachment
gptkbp:difference_from_psychedelics Produce confusion and delirium rather than insight or euphoria
gptkbp:effect gptkb:center
gptkb:Disorientation
gptkb:Hallucinations
gptkb:Delirium
Confusion
Dry mouth
Increased heart rate
Blurred vision
Urinary retention
Dilated pupils
Hyperthermia
Impaired cognition
Impaired memory
https://www.w3.org/2000/01/rdf-schema#label Deliriant hallucinogens
gptkbp:legalStatus Varies by country
gptkbp:mechanismOfAction Anticholinergic
Muscarinic acetylcholine receptor antagonist
gptkbp:notable_plant_sources gptkb:Datura
gptkb:Brugmansia
gptkb:Mandragora_officinarum
gptkb:Atropa_belladonna
gptkb:Hyoscyamus_niger
gptkbp:notable_synthetic_sources gptkb:Diphenhydramine
Chlorpheniramine
Doxylamine
Orphenadrine
gptkbp:riskFactor gptkb:Overdose
death
Poisoning
Toxicity
Accidental injury
High potential for harm
Long-term cognitive impairment
Unpredictable effects
gptkbp:subclassOf gptkb:Hallucinogens
Psychoactive drugs
gptkbp:uses Historically used in medicine
Historically used in witchcraft
Rarely used recreationally
Used in traditional rituals
gptkbp:bfsParent gptkb:Hallucinogens
gptkbp:bfsLayer 7